MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.atherosclerosis.2026.120698

Медицинская библиотека · Atherosclerosis · 2026

Metabolic dysfunction-associated steatotic liver disease and incident coronary events with revascularization: A nationwide cohort study.

Kim Minhong, Lee Hyun-Ah, Kim Joungyoun, Kang Hee-Taik

СтатьяПеревод в очереди

Аннотация

BACKGROUND AND AIMS: Metabolic dysfunction-associated steatotic liver disease (MASLD), a new diagnostic category replacing non-alcoholic fatty liver disease (NAFLD), is strongly linked to cardiovascular diseases. Most previous studies defined cardiovascular outcomes broadly and relied only on diagnostic codes, limiting clinical specificity. We aimed to investigate whether MASLD, defined using the fatty liver index (FLI), is associated with an increased risk of acute coronary syndrome (ACS) and myocardial infarction (MI) with revascularization in the Korean general population.

METHODS

We analyzed 211,881 adults from the Korean NHIS-HEALS cohort who underwent health screening in 2009-2010. MASLD was defined using the fatty liver index (FLI ≥30) in combination with at least one metabolic risk factor, while excluding heavy alcohol intake and viral hepatitis. The primary outcomes were ACS and MI with revascularization, identified using both diagnostic and procedure codes. Cox proportional hazards models were applied, adjusting for cardiovascular, lifestyle, and socioeconomic factors.

RESULTS

Individuals with MASLD had a higher cumulative incidence of ACS and MI compared with non-MASLD. Compared to those without MASLD, fully adjusted HRs (95% CIs) for ACS with revascularization were 1.34 (1.16-1.55) and 1.35 (1.08-1.68) in men with intermediate-risk and high-risk MASLD, and 1.44 (1.16-1.79) and 1.16 (0.76-1.77) in women. A comparable association was found for MI with revascularization.

CONCLUSIONS

MASLD was significantly associated with an increased risk of ACS and MI with revascularization. These findings support MASLD as an early marker and potential preventive target for atherosclerotic cardiovascular disease.

Для цитирования: Kim Minhong, Lee Hyun-Ah, Kim Joungyoun, Kang Hee-Taik. Metabolic dysfunction-associated steatotic liver disease and incident coronary events with revascularization: A nationwide cohort study.. Atherosclerosis. 2026. DOI: 10.1016/j.atherosclerosis.2026.120698.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.